Similar articles

• Antibacterial agents that inhibit lipid A biosynthesis.

  Onishi HR, Pelak BA, Gerckens LS, Silver LL, Kahan FM, Chen MH, Patchett AA, Galloway SM, Hyland SA, Anderson MS, Raetz CR. Onishi HR, et al. Science. 1996 Nov 8;274(5289):980-2. doi: 10.1126/science.274.5289.980. Science. 1996. PMID: 8875939
• Carbohydroxamido-oxazolidines: antibacterial agents that target lipid A biosynthesis.

  Chen MH, Steiner MG, de Laszlo SE, Patchett AA, Anderson MS, Hyland SA, Onishi HR, Silver LL, Raetz CR. Chen MH, et al. Bioorg Med Chem Lett. 1999 Feb 8;9(3):313-8. doi: 10.1016/s0960-894x(98)00749-5. Bioorg Med Chem Lett. 1999. PMID: 10091675
• Inhibition of lipid A biosynthesis as the primary mechanism of CHIR-090 antibiotic activity in Escherichia coli.

  Barb AW, McClerren AL, Snehelatha K, Reynolds CM, Zhou P, Raetz CR. Barb AW, et al. Biochemistry. 2007 Mar 27;46(12):3793-802. doi: 10.1021/bi6025165. Epub 2007 Mar 3. Biochemistry. 2007. PMID: 17335290 Free PMC article.
• Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC.

  Erwin AL. Erwin AL. Cold Spring Harb Perspect Med. 2016 Jul 1;6(7):a025304. doi: 10.1101/cshperspect.a025304. Cold Spring Harb Perspect Med. 2016. PMID: 27235477 Free PMC article. Review.
• Recent Process in the Inhibitors of UDP-3-O-(R-3-hydroxyacyl)-Nacetylglucosamine Deacetylase (LpxC) Against Gram-Negative Bacteria.

  Liu F, Ma S. Liu F, et al. Mini Rev Med Chem. 2018;18(4):310-323. doi: 10.2174/1389557516666161013120253. Mini Rev Med Chem. 2018. PMID: 27739357 Review.